Tuesday, December 16, 2014 2:42:08 PM
Doc 186 PDF file
https://www.scribd.com/doc/250313132/SEC-v-Spencer-Pharmaceutical-Inc-Et-Al-Doc-186-Filed-15-Dec-14
Extract -
At this time, the SEC is unable to apprise the Court as to Defendant Jean-François Amyot’s position on this motion. Since the morning of November 17, 2014, Amyot has not responded to any telephone calls or e-mail communications from counsel to the SEC. As required by the Local Rules, undersigned counsel attempted to contact Amyot via e-mail shortly after 9:00 am this morning to meet and confer regarding this motion to adjourn, but as of 4:00 pm today, Amyot had not responded.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM